ID   TPM1_HUMAN              Reviewed;         284 AA.
AC   P09493; B7Z5T7; D9YZV2; D9YZV3; D9YZV8; P09494; P10469; Q6DV89; Q6DV90;
AC   Q7Z6L8; Q86W64; Q96IK2; Q9UCI1; Q9UCI2; Q9UCY9; Q9Y427;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 2.
DT   18-JUN-2025, entry version 243.
DE   RecName: Full=Tropomyosin alpha-1 chain;
DE   AltName: Full=Alpha-tropomyosin;
DE   AltName: Full=Tropomyosin-1;
GN   Name=TPM1; Synonyms=C15orf13, TMSA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   PROTEIN SEQUENCE (ISOFORM 1), AND ACETYLATION AT MET-1.
RX   PubMed=3548719; DOI=10.1016/0006-291x(87)91486-0;
RA   Mische S.M., Manjula B.N., Fischetti V.A.;
RT   "Relation of streptococcal M protein with human and rabbit tropomyosin: the
RT   complete amino acid sequence of human cardiac alpha tropomyosin, a highly
RT   conserved contractile protein.";
RL   Biochem. Biophys. Res. Commun. 142:813-818(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   TISSUE=Fibroblast;
RX   PubMed=3336357; DOI=10.1128/mcb.8.1.160-168.1988;
RA   Lin C.-S., Leavitt J.;
RT   "Cloning and characterization of a cDNA encoding transformation-sensitive
RT   tropomyosin isoform 3 from tumorigenic human fibroblasts.";
RL   Mol. Cell. Biol. 8:160-168(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3).
RX   PubMed=3336363; DOI=10.1128/mcb.8.1.433-440.1988;
RA   McLeod A.R., Gooding C.;
RT   "Human hTM alpha gene: expression in muscle and nonmuscle tissue.";
RL   Mol. Cell. Biol. 8:433-440(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 6), AND TISSUE SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=15249230; DOI=10.1016/j.bbrc.2004.06.084;
RA   Denz C.R., Narshi A., Zajdel R.W., Dube D.K.;
RT   "Expression of a novel cardiac-specific tropomyosin isoform in humans.";
RL   Biochem. Biophys. Res. Commun. 320:1291-1297(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2009) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 5).
RC   TISSUE=Brain, Hippocampus, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 58-284 (ISOFORM 2).
RC   TISSUE=Liver;
RX   PubMed=3138425; DOI=10.1007/bf02100079;
RA   Colote S., Widada J.S., Ferraz C., Bonhomme F., Marti J., Liautard J.-P.;
RT   "Evolution of tropomyosin functional domains: differential splicing and
RT   genomic constraints.";
RL   J. Mol. Evol. 27:228-235(1988).
RN   [12]
RP   PROTEIN SEQUENCE OF 134-149 AND 153-167.
RC   TISSUE=Colon;
RX   PubMed=8450225;
RA   Das K.M., Dasgupta A., Mandal A., Geng X.;
RT   "Autoimmunity to cytoskeletal protein tropomyosin. A clue to the
RT   pathogenetic mechanism for ulcerative colitis.";
RL   J. Immunol. 150:2487-2493(1993).
RN   [13]
RP   MASS SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RX   PubMed=11840567;
RX   DOI=10.1002/1615-9861(200202)2:2<212::aid-prot212>3.0.co;2-h;
RA   Harris R.A., Yang A., Stein R.C., Lucy K., Brusten L., Herath A.,
RA   Parekh R., Waterfield M.D., O'Hare M.J., Neville M.A., Page M.J.,
RA   Zvelebil M.J.;
RT   "Cluster analysis of an extensive human breast cancer cell line protein
RT   expression map database.";
RL   Proteomics 2:212-223(2002).
RN   [14]
RP   PHOSPHORYLATION AT SER-283, AND MUTAGENESIS OF SER-283.
RX   PubMed=17895359; DOI=10.1242/jcs.003251;
RA   Houle F., Poirier A., Dumaresq J., Huot J.;
RT   "DAP kinase mediates the phosphorylation of tropomyosin-1 downstream of the
RT   ERK pathway, which regulates the formation of stress fibers in response to
RT   oxidative stress.";
RL   J. Cell Sci. 120:3666-3677(2007).
RN   [15]
RP   TISSUE SPECIFICITY, AND IDENTIFICATION BY MASS SPECTROMETRY.
RA   Ahamed M.E.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-213 (ISOFORMS 10; 3; 4 AND 8),
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   FUNCTION, CHARACTERIZATION OF VARIANTS CMH3 ASN-175 AND GLY-180, AND
RP   SUBUNIT.
RX   PubMed=23170982; DOI=10.1021/bi301323n;
RA   Janco M., Kalyva A., Scellini B., Piroddi N., Tesi C., Poggesi C.,
RA   Geeves M.A.;
RT   "alpha-Tropomyosin with a D175N or E180G mutation in only one chain differs
RT   from tropomyosin with mutations in both chains.";
RL   Biochemistry 51:9880-9890(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-174, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-31 (ISOFORM 2), PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-51 (ISOFORM 5), AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   INTERACTION WITH LMOD2.
RX   PubMed=26873245; DOI=10.1016/j.bbapap.2016.02.009;
RA   Colpan M., Tolkatchev D., Grover S., Helms G.L., Cort J.R., Moroz N.,
RA   Kostyukova A.S.;
RT   "Localization of the binding interface between leiomodin-2 and alpha-
RT   tropomyosin.";
RL   Biochim. Biophys. Acta 1864:523-530(2016).
RN   [22]
RP   VARIANTS CMH3 ASN-175 AND GLY-180.
RX   PubMed=8205619; DOI=10.1016/0092-8674(94)90054-x;
RA   Thierfelder L., Watkins H., Macrae C., Lamas R., McKenna W.J.,
RA   Vosberg H.-P., Seidman J.G., Seidman C.E.;
RT   "Alpha-tropomyosin and cardiac troponin T mutations cause familial
RT   hypertrophic cardiomyopathy: a disease of the sarcomere.";
RL   Cell 77:701-712(1994).
RN   [23]
RP   VARIANTS CMH3 VAL-63 AND ASN-175.
RX   PubMed=8523464; DOI=10.1016/0022-2828(95)90026-8;
RA   Nakajima-Taniguchi C., Matsui H., Nagata S., Kishimoto T.,
RA   Yamauchi-Takihara K.;
RT   "Novel missense mutation in alpha-tropomyosin gene found in Japanese
RT   patients with hypertrophic cardiomyopathy.";
RL   J. Mol. Cell. Cardiol. 27:2053-2058(1995).
RN   [24]
RP   VARIANT CMH3 ASN-175.
RX   PubMed=7898523; DOI=10.1056/nejm199504203321603;
RA   Watkins H., McKenna W.J., Thierfelder L., Suk H.J., Anan R., O'Donoghue A.,
RA   Spirito P., Matsumori A., Moravec C.S., Seidman J.G., Seidman C.E.;
RT   "Mutations in the genes for cardiac troponin T and alpha-tropomyosin in
RT   hypertrophic cardiomyopathy.";
RL   N. Engl. J. Med. 332:1058-1064(1995).
RN   [25]
RP   VARIANT CMH3 ASN-175.
RX   PubMed=9822100; DOI=10.1016/s0735-1097(98)00448-3;
RA   Jaeaeskelaeinen P., Soranta M., Miettinen R., Saarinen L., Pihlajamaeki J.,
RA   Silvennoinen K., Tikanoja T., Laakso M., Kuusisto J.;
RT   "The cardiac beta-myosin heavy chain gene is not the predominant gene for
RT   hypertrophic cardiomyopathy in the Finnish population.";
RL   J. Am. Coll. Cardiol. 32:1709-1716(1998).
RN   [26]
RP   VARIANTS CMD1Y LYS-40 AND LYS-54.
RX   PubMed=11273725; DOI=10.1006/jmcc.2000.1339;
RA   Olson T.M., Kishimoto N.Y., Whitby F.G., Michels V.V.;
RT   "Mutations that alter the surface charge of alpha-tropomyosin are
RT   associated with dilated cardiomyopathy.";
RL   J. Mol. Cell. Cardiol. 33:723-732(2001).
RN   [27]
RP   VARIANT CMH3 VAL-180.
RX   PubMed=12974739; DOI=10.1034/j.1399-0004.2003.00151.x;
RA   Erdmann J., Daehmlow S., Wischke S., Senyuva M., Werner U., Raible J.,
RA   Tanis N., Dyachenko S., Hummel M., Hetzer R., Regitz-Zagrosek V.;
RT   "Mutation spectrum in a large cohort of unrelated consecutive patients with
RT   hypertrophic cardiomyopathy.";
RL   Clin. Genet. 64:339-349(2003).
RN   [28]
RP   VARIANTS LVNC9 LYS-192 AND GLU-248.
RX   PubMed=21551322; DOI=10.1161/circgenetics.110.959270;
RA   Probst S., Oechslin E., Schuler P., Greutmann M., Boye P., Knirsch W.,
RA   Berger F., Thierfelder L., Jenni R., Klaassen S.;
RT   "Sarcomere gene mutations in isolated left ventricular noncompaction
RT   cardiomyopathy do not predict clinical phenotype.";
RL   Circ. Cardiovasc. Genet. 4:367-374(2011).
CC   -!- FUNCTION: Binds to actin filaments in muscle and non-muscle cells
CC       (PubMed:23170982). Plays a central role, in association with the
CC       troponin complex, in the calcium dependent regulation of vertebrate
CC       striated muscle contraction (PubMed:23170982). Smooth muscle
CC       contraction is regulated by interaction with caldesmon. In non-muscle
CC       cells is implicated in stabilizing cytoskeleton actin filaments.
CC   -!- SUBUNIT: Homodimer (PubMed:23170982). Heterodimer of an alpha (TPM1,
CC       TPM3 or TPM4) and a beta (TPM2) chain (By similarity). Interacts with
CC       HRG (via the HRR domain); the interaction contributes to the
CC       antiangiogenic properties of the histidine/proline-rich region (HRR) of
CC       HRG (By similarity). Interacts (via N-terminus) with LMOD2 (via N-
CC       terminus) and TMOD1 (via N-terminus) (PubMed:26873245). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P04268, ECO:0000250|UniProtKB:P04692,
CC       ECO:0000269|PubMed:23170982, ECO:0000269|PubMed:26873245}.
CC   -!- INTERACTION:
CC       P09493; Q8TAB5: C1orf216; NbExp=3; IntAct=EBI-351158, EBI-747505;
CC       P09493; Q8TC20: CAGE1; NbExp=3; IntAct=EBI-351158, EBI-10196469;
CC       P09493; Q08379: GOLGA2; NbExp=3; IntAct=EBI-351158, EBI-618309;
CC       P09493; Q9BQD3: KXD1; NbExp=6; IntAct=EBI-351158, EBI-739657;
CC       P09493; Q9Y6D9: MAD1L1; NbExp=7; IntAct=EBI-351158, EBI-742610;
CC       P09493; Q8N0S2: SYCE1; NbExp=4; IntAct=EBI-351158, EBI-6872807;
CC       P09493; P13805: TNNT1; NbExp=4; IntAct=EBI-351158, EBI-726527;
CC       P09493; P07951: TPM2; NbExp=3; IntAct=EBI-351158, EBI-352633;
CC       P09493-5; Q08379: GOLGA2; NbExp=3; IntAct=EBI-10196387, EBI-618309;
CC       P09493-5; V9HW56: HEL-S-108; NbExp=3; IntAct=EBI-10196387, EBI-10330141;
CC       P09493-5; Q9BQD3: KXD1; NbExp=3; IntAct=EBI-10196387, EBI-739657;
CC       P09493-5; Q8N0S2: SYCE1; NbExp=3; IntAct=EBI-10196387, EBI-6872807;
CC       P09493-5; P0C1Z6-2: TFPT; NbExp=3; IntAct=EBI-10196387, EBI-10178002;
CC       P09493-10; Q9UL45: BLOC1S6; NbExp=5; IntAct=EBI-12123928, EBI-465781;
CC       P09493-10; Q8TC20-4: CAGE1; NbExp=4; IntAct=EBI-12123928, EBI-11522698;
CC       P09493-10; Q8TD31-3: CCHCR1; NbExp=3; IntAct=EBI-12123928, EBI-10175300;
CC       P09493-10; Q2M329: CFAP184; NbExp=3; IntAct=EBI-12123928, EBI-12382974;
CC       P09493-10; Q8IZT9: FAM9C; NbExp=3; IntAct=EBI-12123928, EBI-2870039;
CC       P09493-10; P02671-2: FGA; NbExp=3; IntAct=EBI-12123928, EBI-9640259;
CC       P09493-10; Q08379: GOLGA2; NbExp=3; IntAct=EBI-12123928, EBI-618309;
CC       P09493-10; O14879: IFIT3; NbExp=4; IntAct=EBI-12123928, EBI-745127;
CC       P09493-10; Q9BQD3: KXD1; NbExp=7; IntAct=EBI-12123928, EBI-739657;
CC       P09493-10; Q9Y6D9: MAD1L1; NbExp=6; IntAct=EBI-12123928, EBI-742610;
CC       P09493-10; P62195: PSMC5; NbExp=3; IntAct=EBI-12123928, EBI-357745;
CC       P09493-10; Q8N0S2: SYCE1; NbExp=4; IntAct=EBI-12123928, EBI-6872807;
CC       P09493-10; P0C1Z6: TFPT; NbExp=3; IntAct=EBI-12123928, EBI-1245626;
CC       P09493-10; P13805-3: TNNT1; NbExp=4; IntAct=EBI-12123928, EBI-12151635;
CC       P09493-10; O95619: YEATS4; NbExp=3; IntAct=EBI-12123928, EBI-399269;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:P04692}. Note=Associates with F-actin stress
CC       fibers. {ECO:0000250|UniProtKB:P04692}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=10;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=Skeletal muscle, TPM1alpha;
CC         IsoId=P09493-1; Sequence=Displayed;
CC       Name=2; Synonyms=Smooth muscle;
CC         IsoId=P09493-2; Sequence=VSP_006576, VSP_006578, VSP_006579;
CC       Name=3; Synonyms=Fibroblast, TM3;
CC         IsoId=P09493-3; Sequence=VSP_006577, VSP_006579;
CC       Name=4;
CC         IsoId=P09493-4; Sequence=VSP_006577;
CC       Name=5;
CC         IsoId=P09493-5; Sequence=VSP_017498, VSP_017499;
CC       Name=6; Synonyms=10, TPM1kappa;
CC         IsoId=P09493-6; Sequence=VSP_036064;
CC       Name=7;
CC         IsoId=P09493-7; Sequence=VSP_036064, VSP_006579;
CC       Name=8;
CC         IsoId=P09493-8; Sequence=VSP_047297, VSP_047298, VSP_047299,
CC                                  VSP_047300, VSP_006579;
CC       Name=9;
CC         IsoId=P09493-9; Sequence=VSP_006579;
CC       Name=10;
CC         IsoId=P09493-10; Sequence=VSP_047299, VSP_047300, VSP_047301;
CC   -!- TISSUE SPECIFICITY: Detected in primary breast cancer tissues but
CC       undetectable in normal breast tissues in Sudanese patients. Isoform 1
CC       is expressed in adult and fetal skeletal muscle and cardiac tissues,
CC       with higher expression levels in the cardiac tissues. Isoform 10 is
CC       expressed in adult and fetal cardiac tissues, but not in skeletal
CC       muscle. {ECO:0000269|PubMed:15249230, ECO:0000269|Ref.15}.
CC   -!- DOMAIN: The molecule is in a coiled coil structure that is formed by 2
CC       polypeptide chains. The sequence exhibits a prominent seven-residues
CC       periodicity.
CC   -!- PTM: Phosphorylated at Ser-283 by DAPK1 in response to oxidative stress
CC       and this phosphorylation enhances stress fiber formation in endothelial
CC       cells. {ECO:0000269|PubMed:17895359}.
CC   -!- MASS SPECTROMETRY: [Isoform 3]: Mass=32875.93; Method=MALDI; Note=The
CC       measured range is 1-284.; Evidence={ECO:0000269|PubMed:11840567};
CC   -!- DISEASE: Cardiomyopathy, familial hypertrophic, 3 (CMH3) [MIM:115196]:
CC       A hereditary heart disorder characterized by ventricular hypertrophy,
CC       which is usually asymmetric and often involves the interventricular
CC       septum. The symptoms include dyspnea, syncope, collapse, palpitations,
CC       and chest pain. They can be readily provoked by exercise. The disorder
CC       has inter- and intrafamilial variability ranging from benign to
CC       malignant forms with high risk of cardiac failure and sudden cardiac
CC       death. {ECO:0000269|PubMed:12974739, ECO:0000269|PubMed:23170982,
CC       ECO:0000269|PubMed:7898523, ECO:0000269|PubMed:8205619,
CC       ECO:0000269|PubMed:8523464, ECO:0000269|PubMed:9822100}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Cardiomyopathy, dilated, 1Y (CMD1Y) [MIM:611878]: A disorder
CC       characterized by ventricular dilation and impaired systolic function,
CC       resulting in congestive heart failure and arrhythmia. Patients are at
CC       risk of premature death. {ECO:0000269|PubMed:11273725}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Left ventricular non-compaction 9 (LVNC9) [MIM:611878]: A form
CC       of left ventricular non-compaction, a cardiomyopathy due to myocardial
CC       morphogenesis arrest and characterized by a hypertrophic left
CC       ventricle, a severely thickened 2-layered myocardium, numerous
CC       prominent trabeculations, deep intertrabecular recesses, and poor
CC       systolic function. Clinical manifestations are variable. Some affected
CC       individuals experience no symptoms at all, others develop heart
CC       failure. In some cases, left ventricular non-compaction is associated
CC       with other congenital heart anomalies. LVNC9 is an autosomal dominant
CC       condition. {ECO:0000269|PubMed:21551322}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 2]: Incomplete sequence. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the tropomyosin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M19267; AAA36771.1; -; mRNA.
DR   EMBL; M19713; AAA61225.1; -; mRNA.
DR   EMBL; M19714; AAA61226.1; -; mRNA.
DR   EMBL; M19715; AAA61227.1; -; mRNA.
DR   EMBL; AY640414; AAT68294.1; -; mRNA.
DR   EMBL; AY640415; AAT68295.1; -; mRNA.
DR   EMBL; AK299387; BAH13023.1; -; mRNA.
DR   EMBL; AL050179; CAB43309.2; -; mRNA.
DR   EMBL; GU324929; ADL14500.1; -; Genomic_DNA.
DR   EMBL; GU324930; ADL14501.1; -; Genomic_DNA.
DR   EMBL; GU324933; ADL14504.1; -; Genomic_DNA.
DR   EMBL; GU324935; ADL14506.1; -; Genomic_DNA.
DR   EMBL; AC079328; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471082; EAW77619.1; -; Genomic_DNA.
DR   EMBL; CH471082; EAW77622.1; -; Genomic_DNA.
DR   EMBL; CH471082; EAW77623.1; -; Genomic_DNA.
DR   EMBL; CH471082; EAW77627.1; -; Genomic_DNA.
DR   EMBL; CH471082; EAW77628.1; -; Genomic_DNA.
DR   EMBL; BC007433; AAH07433.1; -; mRNA.
DR   EMBL; BC050473; AAH50473.1; -; mRNA.
DR   EMBL; BC053545; AAH53545.1; -; mRNA.
DR   EMBL; X12369; CAA30930.1; -; mRNA.
DR   CCDS; CCDS10181.1; -. [P09493-10]
DR   CCDS; CCDS32262.1; -. [P09493-7]
DR   CCDS; CCDS32263.1; -. [P09493-3]
DR   CCDS; CCDS32264.1; -. [P09493-5]
DR   CCDS; CCDS45273.1; -. [P09493-1]
DR   CCDS; CCDS58368.1; -. [P09493-8]
DR   CCDS; CCDS58369.1; -. [P09493-9]
DR   CCDS; CCDS86459.1; -. [P09493-6]
DR   PIR; A27674; A27674.
DR   PIR; A27678; A25825.
DR   PIR; S05585; S05585.
DR   RefSeq; NP_000357.3; NM_000366.5. [P09493-10]
DR   RefSeq; NP_001018004.1; NM_001018004.2. [P09493-9]
DR   RefSeq; NP_001018005.1; NM_001018005.2. [P09493-1]
DR   RefSeq; NP_001018006.1; NM_001018006.2. [P09493-3]
DR   RefSeq; NP_001018007.1; NM_001018007.2. [P09493-7]
DR   RefSeq; NP_001018008.1; NM_001018008.2. [P09493-5]
DR   RefSeq; NP_001018020.1; NM_001018020.2. [P09493-8]
DR   RefSeq; NP_001288173.1; NM_001301244.2. [P09493-6]
DR   RefSeq; NP_001317273.1; NM_001330344.1.
DR   RefSeq; NP_001317275.1; NM_001330346.1.
DR   RefSeq; NP_001317280.1; NM_001330351.1.
DR   RefSeq; NP_001394259.1; NM_001407330.1. [P09493-10]
DR   RefSeq; NP_001394260.1; NM_001407331.1. [P09493-4]
DR   PDB; 3MUD; X-ray; 2.20 A; C/D=1-29.
DR   PDB; 5KHT; X-ray; 1.50 A; A/B/C/D=1-28.
DR   PDB; 6UT2; NMR; -; B/C=1-14.
DR   PDB; 6X5Z; EM; 4.24 A; O/P=1-284.
DR   PDB; 7UTI; EM; 4.80 A; W/b/e/f/g/h/i/j=1-284.
DR   PDB; 7UTL; EM; 6.60 A; W/Z/a/b/g/h/i/j=1-284.
DR   PDB; 8EFH; EM; 3.30 A; O/P=1-284.
DR   PDB; 8EFI; EM; 3.40 A; O/P=1-284.
DR   PDB; 8ENC; EM; 3.60 A; O/P=1-284.
DR   PDB; 8ZB7; EM; 3.19 A; L/N/O/P=45-210.
DR   PDBsum; 3MUD; -.
DR   PDBsum; 5KHT; -.
DR   PDBsum; 6UT2; -.
DR   PDBsum; 6X5Z; -.
DR   PDBsum; 7UTI; -.
DR   PDBsum; 7UTL; -.
DR   PDBsum; 8EFH; -.
DR   PDBsum; 8EFI; -.
DR   PDBsum; 8ENC; -.
DR   PDBsum; 8ZB7; -.
DR   AlphaFoldDB; P09493; -.
DR   BMRB; P09493; -.
DR   EMDB; EMD-0728; -.
DR   EMDB; EMD-0729; -.
DR   EMDB; EMD-22067; -.
DR   EMDB; EMD-28082; -.
DR   EMDB; EMD-28083; -.
DR   EMDB; EMD-28270; -.
DR   EMDB; EMD-39896; -.
DR   SMR; P09493; -.
DR   BioGRID; 113021; 287.
DR   FunCoup; P09493; 635.
DR   IntAct; P09493; 115.
DR   MINT; P09493; -.
DR   STRING; 9606.ENSP00000351022; -.
DR   ChEMBL; CHEMBL4295705; -.
DR   DrugBank; DB11638; Artenimol.
DR   DrugBank; DB12695; Phenethyl Isothiocyanate.
DR   GlyGen; P09493; 5 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; P09493; -.
DR   MetOSite; P09493; -.
DR   PhosphoSitePlus; P09493; -.
DR   SwissPalm; P09493; -.
DR   BioMuta; TPM1; -.
DR   DMDM; 136092; -.
DR   CPTAC; CPTAC-1462; -.
DR   CPTAC; CPTAC-1463; -.
DR   CPTAC; CPTAC-1464; -.
DR   jPOST; P09493; -.
DR   MassIVE; P09493; -.
DR   PaxDb; 9606-ENSP00000351022; -.
DR   PeptideAtlas; P09493; -.
DR   ProteomicsDB; 15181; -.
DR   ProteomicsDB; 15182; -.
DR   ProteomicsDB; 15183; -.
DR   ProteomicsDB; 52229; -. [P09493-1]
DR   ProteomicsDB; 52230; -. [P09493-2]
DR   ProteomicsDB; 52231; -. [P09493-3]
DR   ProteomicsDB; 52232; -. [P09493-4]
DR   ProteomicsDB; 52233; -. [P09493-5]
DR   ProteomicsDB; 52234; -. [P09493-6]
DR   ProteomicsDB; 52235; -. [P09493-7]
DR   Pumba; P09493; -.
DR   Antibodypedia; 635; 333 antibodies from 39 providers.
DR   DNASU; 7168; -.
DR   Ensembl; ENST00000267996.11; ENSP00000267996.7; ENSG00000140416.26. [P09493-7]
DR   Ensembl; ENST00000288398.10; ENSP00000288398.6; ENSG00000140416.26. [P09493-10]
DR   Ensembl; ENST00000334895.10; ENSP00000334624.4; ENSG00000140416.26. [P09493-5]
DR   Ensembl; ENST00000358278.7; ENSP00000351022.3; ENSG00000140416.26. [P09493-3]
DR   Ensembl; ENST00000403994.9; ENSP00000385107.4; ENSG00000140416.26. [P09493-1]
DR   Ensembl; ENST00000559397.6; ENSP00000452879.1; ENSG00000140416.26. [P09493-8]
DR   Ensembl; ENST00000559556.5; ENSP00000453941.1; ENSG00000140416.26. [P09493-9]
DR   Ensembl; ENST00000561266.6; ENSP00000453955.2; ENSG00000140416.26. [P09493-6]
DR   GeneID; 7168; -.
DR   KEGG; hsa:7168; -.
DR   MANE-Select; ENST00000403994.9; ENSP00000385107.4; NM_001018005.2; NP_001018005.1.
DR   UCSC; uc002alg.4; human. [P09493-1]
DR   AGR; HGNC:12010; -.
DR   CTD; 7168; -.
DR   DisGeNET; 7168; -.
DR   GeneCards; TPM1; -.
DR   GeneReviews; TPM1; -.
DR   HGNC; HGNC:12010; TPM1.
DR   HPA; ENSG00000140416; Tissue enhanced (heart muscle, skeletal muscle, tongue).
DR   MalaCards; TPM1; -.
DR   MIM; 115196; phenotype.
DR   MIM; 191010; gene.
DR   MIM; 611878; phenotype.
DR   OpenTargets; ENSG00000140416; -.
DR   Orphanet; 154; Familial isolated dilated cardiomyopathy.
DR   Orphanet; 54260; Left ventricular noncompaction.
DR   VEuPathDB; HostDB:ENSG00000140416; -.
DR   GeneTree; ENSGT01030000234542; -.
DR   HOGENOM; CLU_055027_0_0_1; -.
DR   InParanoid; P09493; -.
DR   OrthoDB; 128924at2759; -.
DR   PAN-GO; P09493; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; P09493; -.
DR   PathwayCommons; P09493; -.
DR   Reactome; R-HSA-390522; Striated Muscle Contraction.
DR   Reactome; R-HSA-445355; Smooth Muscle Contraction.
DR   SignaLink; P09493; -.
DR   SIGNOR; P09493; -.
DR   BioGRID-ORCS; 7168; 14 hits in 1165 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; TPM1; human.
DR   GeneWiki; TPM1; -.
DR   GenomeRNAi; 7168; -.
DR   Pharos; P09493; Tbio.
DR   PRO; PR:P09493; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; P09493; protein.
DR   Bgee; ENSG00000140416; Expressed in left ventricle myocardium and 216 other cell types or tissues.
DR   ExpressionAtlas; P09493; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005884; C:actin filament; IBA:GO_Central.
DR   GO; GO:0032059; C:bleb; IMP:BHF-UCL.
DR   GO; GO:0005856; C:cytoskeleton; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005862; C:muscle thin filament tropomyosin; TAS:ProtInc.
DR   GO; GO:0032587; C:ruffle membrane; IDA:BHF-UCL.
DR   GO; GO:0030017; C:sarcomere; TAS:BHF-UCL.
DR   GO; GO:0001725; C:stress fiber; IDA:BHF-UCL.
DR   GO; GO:0003779; F:actin binding; TAS:BHF-UCL.
DR   GO; GO:0051015; F:actin filament binding; ISS:UniProtKB.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:BHF-UCL.
DR   GO; GO:0008307; F:structural constituent of muscle; TAS:ProtInc.
DR   GO; GO:0007015; P:actin filament organization; IBA:GO_Central.
DR   GO; GO:0060048; P:cardiac muscle contraction; IMP:BHF-UCL.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; IEP:BHF-UCL.
DR   GO; GO:0007010; P:cytoskeleton organization; TAS:BHF-UCL.
DR   GO; GO:0030049; P:muscle filament sliding; ISS:BHF-UCL.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISS:BHF-UCL.
DR   GO; GO:1904753; P:negative regulation of vascular associated smooth muscle cell migration; IMP:BHF-UCL.
DR   GO; GO:1904706; P:negative regulation of vascular associated smooth muscle cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; ISS:BHF-UCL.
DR   GO; GO:0003065; P:positive regulation of heart rate by epinephrine; ISS:BHF-UCL.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; ISS:BHF-UCL.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:BHF-UCL.
DR   GO; GO:0008016; P:regulation of heart contraction; TAS:ProtInc.
DR   GO; GO:0006937; P:regulation of muscle contraction; TAS:ProtInc.
DR   GO; GO:0031529; P:ruffle organization; ISS:BHF-UCL.
DR   GO; GO:0045214; P:sarcomere organization; IMP:BHF-UCL.
DR   GO; GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0042060; P:wound healing; ISS:BHF-UCL.
DR   FunFam; 1.20.5.1160:FF:000013; Tropomyosin 1 (alpha); 1.
DR   FunFam; 1.20.5.170:FF:000005; Tropomyosin alpha-1 chain; 1.
DR   FunFam; 1.20.5.170:FF:000001; Tropomyosin alpha-1 chain isoform 1; 1.
DR   FunFam; 1.20.5.340:FF:000001; Tropomyosin alpha-1 chain isoform 2; 1.
DR   Gene3D; 1.20.5.170; -; 2.
DR   Gene3D; 1.20.5.340; -; 1.
DR   InterPro; IPR000533; Tropomyosin.
DR   PANTHER; PTHR19269; TROPOMYOSIN; 1.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   SUPFAM; SSF57997; Tropomyosin; 1.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
DR   neXtProt; NX_P09493; -.
DR   PharmGKB; PA36690; -.
DR   TreeFam; TF351519; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing;
KW   Cardiomyopathy; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Disease variant; Muscle protein; Phosphoprotein;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..284
FT                   /note="Tropomyosin alpha-1 chain"
FT                   /id="PRO_0000205620"
FT   REGION          1..38
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          116..136
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          1..284
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        12..38
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|PubMed:3548719"
FT   MOD_RES         45
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04692"
FT   MOD_RES         174
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         186
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P58771"
FT   MOD_RES         206
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P58771"
FT   MOD_RES         252
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P58771"
FT   MOD_RES         261
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P04692"
FT   MOD_RES         271
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P58771"
FT   MOD_RES         283
FT                   /note="Phosphoserine; by DAPK1"
FT                   /evidence="ECO:0000269|PubMed:17895359"
FT   VAR_SEQ         1..80
FT                   /note="MDAIKKKMQMLKLDKENALDRAEQAEADKKAAEDRSKQLEDELVSLQKKLKG
FT                   TEDELDKYSEALKDAQEKLELAEKKATD -> MCRLRIFLRTASSEHLHERKLRET
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:3138425"
FT                   /id="VSP_006576"
FT   VAR_SEQ         1..80
FT                   /note="MDAIKKKMQMLKLDKENALDRAEQAEADKKAAEDRSKQLEDELVSLQKKLKG
FT                   TEDELDKYSEALKDAQEKLELAEKKATD -> MAGSSSLEAVRRKIRSLQEQADAAEER
FT                   AGTLQRELDHERKLRET (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_017498"
FT   VAR_SEQ         41..80
FT                   /note="DELVSLQKKLKGTEDELDKYSEALKDAQEKLELAEKKATD -> EDIAAKEK
FT                   LLRVSEDERDRVLEELHKAEDSLLAAEEAAAK (in isoform 6 and isoform
FT                   7)"
FT                   /evidence="ECO:0000303|PubMed:15249230,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_036064"
FT   VAR_SEQ         41..53
FT                   /note="DELVSLQKKLKGT -> EDIAAKEKLLRVS (in isoform 8)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047297"
FT   VAR_SEQ         57..80
FT                   /note="LDKYSEALKDAQEKLELAEKKATD -> RDRVLEELHKAEDSLLAAEEAAAK
FT                   (in isoform 8)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047298"
FT   VAR_SEQ         189..212
FT                   /note="KCAELEEELKTVTNNLKSLEAQAE -> QVRQLEEQLRIMDSDLESINAAED
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:3138425"
FT                   /id="VSP_006578"
FT   VAR_SEQ         189..212
FT                   /note="KCAELEEELKTVTNNLKSLEAQAE -> QVRQLEEQLRIMDQTLKALMAAED
FT                   (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:3336357, ECO:0000303|PubMed:3336363"
FT                   /id="VSP_006577"
FT   VAR_SEQ         189..192
FT                   /note="KCAE -> QVRQ (in isoform 8 and isoform 10)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047299"
FT   VAR_SEQ         196..212
FT                   /note="ELKTVTNNLKSLEAQAE -> QLRIMDQTLKALMAAED (in isoform 8
FT                   and isoform 10)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047300"
FT   VAR_SEQ         258..284
FT                   /note="DELYAQKLKYKAISEELDHALNDMTSI -> EKVAHAKEENLSMHQMLDQTL
FT                   LELNNM (in isoform 2, isoform 3, isoform 7, isoform 8 and
FT                   isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:17974005,
FT                   ECO:0000303|PubMed:3138425, ECO:0000303|PubMed:3336357,
FT                   ECO:0000303|PubMed:3336363"
FT                   /id="VSP_006579"
FT   VAR_SEQ         259..284
FT                   /note="ELYAQKLKYKAISEELDHALNDMTSI -> QLYQQLEQNRRLTNELKLALNE
FT                   D (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_017499"
FT   VAR_SEQ         284
FT                   /note="I -> M (in isoform 10)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047301"
FT   VARIANT         40
FT                   /note="E -> K (in CMD1Y; dbSNP:rs104894501)"
FT                   /evidence="ECO:0000269|PubMed:11273725"
FT                   /id="VAR_043986"
FT   VARIANT         54
FT                   /note="E -> K (in CMD1Y; dbSNP:rs104894505)"
FT                   /evidence="ECO:0000269|PubMed:11273725"
FT                   /id="VAR_043987"
FT   VARIANT         63
FT                   /note="A -> V (in CMH3; dbSNP:rs199476306)"
FT                   /evidence="ECO:0000269|PubMed:8523464"
FT                   /id="VAR_013135"
FT   VARIANT         175
FT                   /note="D -> N (in CMH3; no change in homodimerization; no
FT                   change in homodimer thermal stability; decreased actin
FT                   binding; recessive effect in the homodimer; increased
FT                   calcium-dependent regulation of myosin binding to actin
FT                   filaments; dominant effect in the homodimer;
FT                   dbSNP:rs104894503)"
FT                   /evidence="ECO:0000269|PubMed:23170982,
FT                   ECO:0000269|PubMed:7898523, ECO:0000269|PubMed:8205619,
FT                   ECO:0000269|PubMed:8523464, ECO:0000269|PubMed:9822100"
FT                   /id="VAR_007601"
FT   VARIANT         180
FT                   /note="E -> G (in CMH3; no change in homodimerization;
FT                   decreased in hom odimer thermal stability; decreased in
FT                   actin binding; increased calcium-dependent regulation of
FT                   myosin binding to actin filaments; dominant effect in the
FT                   homodimer; dbSNP:rs104894502)"
FT                   /evidence="ECO:0000269|PubMed:23170982,
FT                   ECO:0000269|PubMed:8205619"
FT                   /id="VAR_007602"
FT   VARIANT         180
FT                   /note="E -> V (in CMH3; dbSNP:rs104894502)"
FT                   /evidence="ECO:0000269|PubMed:12974739"
FT                   /id="VAR_029452"
FT   VARIANT         192
FT                   /note="E -> K (in LVNC9; dbSNP:rs199476315)"
FT                   /evidence="ECO:0000269|PubMed:21551322"
FT                   /id="VAR_070121"
FT   VARIANT         248
FT                   /note="K -> E (in LVNC9; dbSNP:rs199476319)"
FT                   /evidence="ECO:0000269|PubMed:21551322"
FT                   /id="VAR_070122"
FT   MUTAGEN         15
FT                   /note="K->N: Impairs interaction with LMOD2 and TMOD1."
FT                   /evidence="ECO:0000269|PubMed:26873245"
FT   MUTAGEN         283
FT                   /note="S->A: Loss of phosphorylation and decreased
FT                   formation of actin stress fibers."
FT                   /evidence="ECO:0000269|PubMed:17895359"
FT   MUTAGEN         283
FT                   /note="S->E: Increased formation of actin stress fibers."
FT                   /evidence="ECO:0000269|PubMed:17895359"
FT   CONFLICT        109
FT                   /note="A -> V (in Ref. 11; CAA30930)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        203
FT                   /note="N -> D (in Ref. 4; AAT68294/AAT68295)"
FT                   /evidence="ECO:0000305"
FT   HELIX           1..28
FT                   /evidence="ECO:0007829|PDB:5KHT"
FT   HELIX           46..209
FT                   /evidence="ECO:0007829|PDB:8EFH"
FT   MOD_RES         P09493-2:31
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         P09493-3:213
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         P09493-4:213
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         P09493-5:51
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         P09493-8:213
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         P09493-10:213
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
SQ   SEQUENCE   284 AA;  32709 MW;  F57139E2B0972F4D CRC64;
     MDAIKKKMQM LKLDKENALD RAEQAEADKK AAEDRSKQLE DELVSLQKKL KGTEDELDKY
     SEALKDAQEK LELAEKKATD AEADVASLNR RIQLVEEELD RAQERLATAL QKLEEAEKAA
     DESERGMKVI ESRAQKDEEK MEIQEIQLKE AKHIAEDADR KYEEVARKLV IIESDLERAE
     ERAELSEGKC AELEEELKTV TNNLKSLEAQ AEKYSQKEDR YEEEIKVLSD KLKEAETRAE
     FAERSVTKLE KSIDDLEDEL YAQKLKYKAI SEELDHALND MTSI
//
